Top 15 biopharma R&D spenders; The return of Big Cardio; Mathai ... - Endpoints News
Top 15 biopharma R&D spenders; The return of Big Cardio; Mathai ... Endpoints News ... Read full article
Top 15 biopharma R&D spenders; The return of Big Cardio; Mathai ... Endpoints News ... Read full article
Rising number of Americans choose bankruptcy to deal with ... FOX 13 Seattle ... Read full article
AT&T SportsNet, Another Regional Sports Network, Could Be Declaring Bankruptcy This Month Forbes ... Read full article
CHMP gives thumbs-up for Wegovy use in adolescents, along with ... Endpoints News ... Read full article
The Limestone Boat Company Announces Fourth Quarter 2022 ... AccessWire ... Read full article
Alector cuts 11% of workforce as it doubles down on late-stage ... Endpoints News ... Read full article
Boehringer reports robust sales led by type 2 diabetes and ... Endpoints News ... Read full article
Galapagos sends some employees — and a research unit — off to ... Endpoints News ... Read full article
Here's what went wrong with Virgin Orbit CNBC ... Read full article
Births | News, Sports, Jobs Altoona Mirror ... Read full article
US government to SCOTUS: Take up the Teva-GSK 'skinny' generic ... Endpoints News ... Read full article
WantAFreshStart announces Bankruptcy means test to find eligibility for bankruptcy EIN News ... Read full article
Farm bankruptcies fall again in 2022 Wisconsin State Farmer ... Read full article
The Limestone Boat Company Announces Fourth Quarter 2022 Results Yahoo Finance ... Read full article
Lupus drug development market heating up, while FDA links with ... Endpoints News ... Read full article
Sartorius to acquire French manufacturer for $2.6B+ in cell and gene ... Endpoints News ... Read full article
Mathai Mammen hands in J&J's R&D keys to lead Greg Verdine's ... Endpoints News ... Read full article
New Jersey Bankruptcy Attorney Daniel Straffi Explains the ... Digital Journal ... Read full article
Sarissa tightens its grip on Amarin as CEO resigns Endpoints News ... Read full article
Acquisition talks ongoing for Swedish rare disease biotech Egetis ... Endpoints News ... Read full article